A UCLA study of more than 14,000 patient-drug pairs finds insurers and patients paid less for biosimilars than for brand-name biologics.

Targeted gene therapies are highly effective at stopping cancers, but the very abundance of the treatments, plus cost and ...

Biologic drugs play an important role in treating cancers such as breast cancer and lymphoma, but their high costs can add to the financial burden of cancer care. Now, lower-cost versions known as ...

Forbes contributors publish independent expert analyses and insights. I am a personal finance expert and writer. Cancer treatment is costly. The average cost of cancer care in the U.S. is around ...

Insurance products known as ‘refill-type insurance,’ where coverage limits are replenished after a certain period even if ...

See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. The Food and Drug Administration (FDA) on Wednesday approved Rasonque, ...

The cost of cancer treatment is steadily rising. Between 2021 and 2026, the average cancer-related insurance claim surged by 81% to approximately ₹5.6 lakh. Given this trend, having adequate health ...

All families that need the countrys advanced cancer treatments are forced to either go broke in the process of getting care or compromise on proper treatment. But while the rest of the industry ...